Safety and patient satisfaction of abobotulinumtoxinA for aesthetic use. A systematic review [PDF]
A systematic review of the published literature (from January 2000 to January 2016) to ascertain the safety of, and patient satisfaction with, the aesthetic use of abobotulinumtoxinA was conducted.
Cohen, Joel L, Scuderi, Nicolo'
core +1 more source
Botulinum toxin and spasticity [PDF]
The clinical effects of botulinum toxin have been recognised since the end of the 19th century. It is the most potent neurotoxin known and it is produced by the gram negative anaerobic bacterium Clostridium botulinum. The paralytic effect of the toxin is due to blockade of neuromuscular transmission.1 Injection into a muscle causes chemodenervation and
Michael P Barnes, Elizabeth C. Davis
openaire +2 more sources
ABSTRACT Background Retrograde Cricopharyngeal Dysfunction (RCPD), also known as “No Burp Syndrome,” is a rare condition characterized by the inability to burp due to cricopharyngeus muscle dysfunction. Patients experience bloating, chest and abdominal discomfort, gurgling sounds, and excessive flatulence, which significantly impact quality of life ...
Salwa AlRashed AlHumaid+2 more
wiley +1 more source
Intravesical antimicrobial administration for urinary tract infections via a dedicated catheter
British Journal of Clinical Pharmacology, EarlyView.
John Posner
wiley +1 more source
Postoperative Fluoroscopic Appearance After Flexible Endoscopic Zenker's Diverticulotomy
We perform a retrospective study on patients undergoing flexible Zenker's diverticulotomy surgery and report changes in the objective fluoroscopic appearance as well as patient‐reported outcome measures. ABSTRACT Objective Flexible approach to treating Zenker's diverticulum (ZD) has gained traction in recent years. However, objective measures comparing
Shumon I. Dhar+7 more
wiley +1 more source
Botulinum toxin type A in chronic neuropathic pain in refractory leprosy
Neuropathic pain is a chronic syndrome that is difficult to treat and often affects patients with leprosy. Recommended treatment includes the the use of analgesic drugs, codeine, tricyclic antidepressants, neuroleptics, anticonvulsants and thalidomide ...
Emanuel de Jesus Soares de Sousa+4 more
doaj +1 more source
Cost-Effectiveness of Treating Upper Limb Spasticity Due to Stroke with Botulinum Toxin Type A: Results from the Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial [PDF]
Stroke imposes significant burdens on health services and society, and as such there is a growing need to assess the cost-effectiveness of stroke treatment to ensure maximum benefit is derived from limited resources.
Christopher Price+16 more
core +3 more sources
Hazard analysis and possibilities for preventing botulism originating from meat products [PDF]
The paper presents the more important data on the bacteria Clostridium botulinum, the appearance of botulism, hazard analysis and the possibilities for preventing botulism.
Vasilev Dragan, Vuković Ilija
doaj +1 more source
Safety and Pharmacokinetics of a Four Monoclonal Antibody Combination Against Botulinum C and D Neurotoxins. [PDF]
Botulism is caused by botulinum neurotoxin (BoNT), the most poisonous substance known. BoNTs are also classified as Tier 1 biothreat agents due to their high potency and lethality.
Cobb, Ronald R+12 more
core
Botulinum toxin-A for the treatment of overactive bladder: UK contributions [PDF]
Background: Botulinum toxin-A (BoNT/A) is now established second-line management for refractory overactivebladder (OAB) and recognised in many incontinence guidelines and pathways.
Dasgupta, P+6 more
core +1 more source